Characteristics of a diagnostic method of tuberculosis infection based on whole blood interferon-γ assay

Kekkaku

Volumn 81, Issue 11, 2006, Pages 681-686

  Harada, Nobuyuki ^a  

^a Research Institute of Tuberculosis   (Japan)

Author keywords

Contact investigation; Diagnosis of tuberculosis infection; Latent tuberculosis infection; Quantiferon TB 2G; Tuberculin skin test

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BIOLOGICAL MARKER; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GAMMA INTERFERON;

BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METHODOLOGY; REVIEW; TUBERCULIN TEST; TUBERCULOSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON TYPE II; TUBERCULIN TEST; TUBERCULOSIS;

EID: 39049187916     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Comstock, GW: Epidemiology of tuberculosis. Am Rev Respir Dis. 1982;125 (suppl.):8-16.
2. World Health Organization: Tuberculosis fact sheet number 104, 2002. (http://www.who.int/mediacentre/factsheets/who 104/en/)
3. Andersen P, Andersen AB, Sorensen AL, et al.: Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995;154:3359-3372.
4. Mahairas GG, Sabo PJ, Hickey MJ, et al. : Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996;178:1274-1282.
5. Andersen P, Munk ME, Pollock JM, et al.: Specific immunebased diagnosis of tuberculosis. Lancet 2000;356:1099-1104.
6. Mori T, Sakatani M, Yamagishi F, et al.: Specific detection of tuberculosis infection with an interferon-gamma based assay using new antigens. Am J Respir Crit Care Med. 2004;170:59-64.
7. Brock I, Weldingh K, Lillebaek T, et al.: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004;170:65-69.
8. Harada N, Nakajima Y, Higuchi K, et al.: Screening for Tuberculosis Infection Using Whole-Blood Interferongamma and Mantoux Testing Among Japanese Healthcare Workers. Infect Control Hosp Epidemiol. 2006;27:442-448.
9. Pai M, Gokhale K, Joshi R, et al.: Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA. 2005;293:2746-2755.
10. Ferrara G, Losi M, Meacci M, et al.: Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2005;172:631-635.
11. Kang YA, Lee HW, Yoon HI, et al.: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005;293:2756-2761.